These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18675067)

  • 1. Clinical operational tolerance after kidney transplantation: a short literature review.
    Berlanda M; Di Cocco P; Mazzotta C; Rizza V; D'Angelo M; Bellini MI; Scelzo C; Famulari A; Pisani F; Hernandez-Fuentes M; Orlando G
    Transplant Proc; 2008; 40(6):1847-51. PubMed ID: 18675067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Prope' tolerance in a noncompliant living related small bowel transplant recipient after severe rejection.
    Asolati M; Testa G; Gangemi A; Sankary H; Oberholzer J; Benedetti E
    Transplantation; 2007 Jan; 83(1):77-9. PubMed ID: 17220796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation.
    Ashton-Chess J; Giral M; Brouard S; Soulillou JP
    Transplantation; 2007 Nov; 84(10):1215-9. PubMed ID: 18049104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney transplantation: Charles Nicolle Hospital experience.
    Bardi R; Cherif M; Goucha R; Ounissi M; Abderrahim E; Ben Hamida F; Makhlouf M; Jendoubi-Ayed S; Ben Romdhane T; Ben Boujemaa S; El Younsi F; Ayed K; Ben Maiz H; Kheder A; Gorgi Y; Ben Abdallah T
    Transplant Proc; 2009 Mar; 41(2):651-3. PubMed ID: 19328946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful tapering of immunosuppression to low-dose monotherapy steroids after living-related human leukocyte antigen-identical renal transplantation.
    van de Wetering J; Gerrits JH; van Besouw NM; Ijzermans JN; Weimar W
    Transplantation; 2009 Mar; 87(5):740-4. PubMed ID: 19295320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
    Opelz G; Döhler B;
    Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal graft outcome in simultaneous kidney transplantation combined with other organs: experience of a single center.
    Gutierrez-Baños J; Portillo J; Ballestero R; Zubillaga S; Ramos E; Campos J; Hidalgo E
    Transplant Proc; 2008 Dec; 40(10):3424-7. PubMed ID: 19100404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter study on double kidney transplantation.
    Bertelli R; Nardo B; Capocasale E; Cappelli G; Cavallari G; Mazzoni MP; Benozzi L; Dalla Valle R; Fuga G; Busi N; Gilioli C; Albertazzi A; Stefoni S; Pinna AD; Faenza A
    Transplant Proc; 2008; 40(6):1869-70. PubMed ID: 18675074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation.
    Yoshitomi M; Koshiba T; Haga H; Li Y; Zhao X; Cheng D; Miyagawa A; Sakashita H; Tsuruyama T; Ohe H; Ueda M; Okamoto S; Egawa H; Wood K; Sakaguchi S; Manabe T; Tanaka K; Uemoto S
    Transplantation; 2009 Feb; 87(4):606-14. PubMed ID: 19307800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: a collaborative transplant study report.
    Süsal C; Döhler B; Sadeghi M; Ovens J; Opelz G
    Transplantation; 2009 May; 87(9):1367-71. PubMed ID: 19424037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal transplantation: evolution in immunosuppression protocols.
    Pirenne J; Kawai M
    Curr Opin Organ Transplant; 2009 Jun; 14(3):250-5. PubMed ID: 19373085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression is essential for successful allogeneic transplantation of the metanephros.
    Clancy MJ; Marshall D; Dilworth M; Bottomley M; Ashton N; Brenchley P
    Transplantation; 2009 Jul; 88(2):151-9. PubMed ID: 19623009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class I antibodies in patients awaiting kidney transplantation and the association with renal graft survival.
    Wu HH; Tien YC; Huang CI; Chiang YJ; Chu SH; Lai PC
    Transplant Proc; 2008 Sep; 40(7):2191-4. PubMed ID: 18790188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of acute humoral kidney allograft rejection.
    Gomes AM; Pedroso S; Martins LS; Malheiro J; Viscayno JR; Santos J; Dias L; Henriques AC; Sarmento AM; Cabrita A
    Transplant Proc; 2009 Apr; 41(3):855-8. PubMed ID: 19376371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.